| Schedule: |
| Monday, October 26 |
Workshop: Advances in Thermoplastic Elastomers
and Biodegradable Polymers: Analysis and
Applications
(Chair: Marc Hendriks, DSM Biomedical) |
7:00 – 8:00 a.m.
8:00 – 8:15 a.m
|
Pre-Registration and Breakfast
Welcome and Introduction |
| Recent Advances in Medical Grade Thermoplastic Elastomers: |
8:15 – 9:00 a.m.
9:00 – 9:45 a.m.
|
“SIBS and Quatroset™ in Medicine”
Len Pinchuk, Innovia LLC
“Evolution of Medical Grade Thermoplastic Polyurethanes: Property Optimization and Process Improvements”
Bob Ward, DSM PTG |
| 9:45– 10:15 a.m. |
Break |
| Recent Advances in Bioresorbable Polymers: |
10:15 – 11:00 a.m.
11:00 – 11:45 a.m.
11:45 – 12:45 p.m.
|
“Recent Advances in Bioabsorbable Polymers”
Kishore Udipi, Biopolymer Designs, Inc.
“Amino Acid Based Bioresorbable Polymers: Exploiting Their Versatility in Degradation Mechanisms”
Aylvin Dias, DSM Biomedical
Lunch |
| Applications of Advanced Medical Grade Polymers: |
12:45 – 1:30 p.m.
1:30 – 2:15 p.m.
2:15 – 3:00 p.m.
|
“Beyond ISO 10993: Challenges for the Future”
Jim Anderson, Case Western Reserve University
“Tooth Attachment: A Biomimetic-Tissue Engineering Approach”
Sunita Ho, UCSF School of Dentistry
“Materials and their Requirements for Continuous Glucose Monitoring”
Bob Boock, Dexcom |
3:00 - 3:30 p.m. |
Break |
Applied Technology Workshops:
(Chair: Peg Palmer, Surface Solutions Labs, Inc.) |
3:30 – 3:50 p.m
3:50 – 4:10 p.m
4:10 – 4:30 p.m |
Biocoat, Inc.
“Configurable Biopolymeric Coatings for Medical Devices with Optional Antimicrobial Protection: The Technology Platform Behind Hydak®”
Bayer MaterialScience LLC
“Bayer Material Science’s Hydrophilic Coatings”
AST Products
“Environmentally Friendly Medical Coatings” |
5:00 - 5:30 p.m. |
BioInterface Symposium Welcome Reception
|
5:30 - 6:30 p.m. |
Keynote Presentation:
“Drug-eluting Stents: Past, Present and Future”
James Barry, Boston Scientific Corporation |
| Tuesday, October 27 |
Surfaces in Biomaterials Foundation BioInterface Symposium |
7:00 – 8:30 a.m.
7:20 – 8:20 a.m. |
Symposium Registration and Breakfast
General Poster Session and Student Poster Judging
(Co-chairs: Carl Turnquist, Genzyme and Rob Kellar, Development Engineering Sciences) |
8:20 – 8:30 a.m. |
President’s Welcome, Joe Chinn |
Recent Advances in Biodegradable Systems:
(Co-chairs: Peter Markland, SurModics Pharmaceuticals, Jim Arps, SurModics) |
8:30-8:50 a.m.
8:50-9:10 a.m.
|
“Application of Reservoir Stent Technology for Simultaneous Multiple Drug Release”
Victoria Rogers, Cordis Corporation
“Methods for Evaluating Local Delivery of Drugs to Arterial Tissue via Endovascular Devices”
Mark E. Smith, American Preclinical Services |
9:10-9:30 a.m.
9:30-9:50 a.m.
9:50-10:10 a.m.
|
“Development of DES with Biodegradable Polymer Matrix”
Ya Guo, Medtronic Vascular
“Novel Ter Polymer and Hexyl PLA for Drug Delivery”
Peter Markland, SurModics Pharmaceuticals
“Comparison of SynBiosys™ Urethane-linked Multi-block Copolymer and PLGA Coatings”
Nathan Lockwood, SurModics, Inc.
|
| 10:10-10:30 a.m. |
Break |
Next Generation Drug Eluting Stents:
(Chair: Mikael Trollsas, Abbott Vascular)
|
11:00-11:20 a.m.
11:20-11:40 a.m.
|
“Fully Bioabsorbable Coronary Scaffolds: How Do They Work?”
Thierry Glauser, Abbott Vascular
“Thromboresistant Reservoir Technology™ Based Sirolimus Eluting Stent with Bound Heparin Surface”
Cheng Li, Cordis, a Johnson and Johnson Company |
11:40 a.m.-12:00 p.m. |
“Release Kinetics for a Cilostazol Eluting Stent Using Reservoir Technology”
Ted Parker, Cordis, a Johnson and Johnson Company |
12:00-1:00 p.m. |
Student Town Hall Meeting and Attendee Luncheon
(Co-chairs: Carl Turnquist, Genzyme and Rob Kellar, Development Engineering Sciences) |
1:00-1:30 p.m. |
Surfaces in Biomaterials Foundation Business Meeting |
Surface Interaction Designs for Controlled Biological Responses:
(Co-chairs: Joseph Berglund and Susan Rea Peterson, Medtronic CardioVascular) |
| 1:30-2:00 p.m. |
Invited Speaker
“Hybrid Drug/Device Strategies for the Treatment of AAA Disease”
Geoffrey Schultz, Stanford University |
2:00-2:20 p.m.
2:20-2:40 p.m.
|
“Artificial Cell Membrane Based on Phospholipid Polymer Chemistry for Regulating Biological Response on the Medical Devices”
Kazuhiko Ishihara, The University of Tokyo
“Novel Polymer Coatings for Prevention of Biofilms in Dental Unit Waterlines”
Arinne Lyman, Nerites Corporation |
2:40-3:00 p.m.
3:00-3:20 p.m.
|
“Benefits of Crystalline HA Surfaces for Metallic Implants”
John O’Donoghue, University of Ulster, Jordanstown
“On Surface-induced Non-native Protein Aggregation”
Christophe Bureau, BD Medical - Pharmaceutical Systems |
3:20-3:40 p.m. |
Break |
3:40-5:00 p.m. |
Point-Counterpoint Session
(Chair: Carl Turnquist, Genzyme)
“Be it Resolved that in Vitro Biological Assays Provide Little Predictive Relevance for Validating Human in Vivo Responses to Implanted Devices”
Debater 1: David Grainger, Univ. Utah
Debater 2: Kevin Healy, Univ. Cal. Berkeley
|
| Wednesday, October 28 |
8:00-8:30 a.m. |
Breakfast & Registration |
8:30-9:30 a.m. |
Cell and Protein Interactions with Biomaterials (Podium and Poster Session)
(Co-chairs: Gene Boland, Cardiovascular Innovation Institute & Kahlid Kader, University of Iowa)
This will be a brief session of 5-minute introductions by
poster presenters about the topic of their posters. Once
the presenters finish, you will be given a chance to discuss the presenters’ topics with them at their respective posters.
“Complement Adsorption on Biomaterial Surfaces”
Sheryl Kane, EIC Laboratories, Inc.
“Antimicrobial Coatings Based on Amine Plasma Polymer Films Loaded with Silver Nanoparticles”
Krasimir Vasilev, University of South Australia
“Inhibition of Bacterial Attachment by Mussel-Inspired Coatings on Urinary Stent and Catheter Materials”
Baiyan Dong, Nerites Corporation
“Preparation of Contact Lens Materials for Real-Time Protein Adsorption Studies by QCM-D”
Matthew C. Dixon, Q-Sense. a Division of Biolin Inc.
“Proteomic Characterization of Human Plasma Protein Adsorption onto Biomimetic Glycocalyx Surfaces”
Irene Y. Tsai, University of Pennsylvania
“Quantitative Characterization of Biomaterial to Assist Human Test Panels”
S. Kuiry, Center for Tribology, Inc.
“Novel Tissue Section Analysis Using Whole Slide Imaging for Studying the Tissue-Biomaterial Interface”
Steven J. Potts, Aperio Technologies |
9:30 - 10:15 a.m.
10:15-10:30 a.m. |
Podium/Poster session
Break
|
Stability of Biomaterials in Clinical Applications:
(Chair: Jeremy L. Gilbert, University of Syracuse) |
10:30-10:50 a.m.
|
“Titanium is Not ‘The Most Biocompatible Metal’ Under Cathodic Electrochemical Potential”
Jeremy L. Gilbert, University of Syracuse |
10:50-11:10 a.m.
11:10-11:30 a.m.
|
“Surface Properties of Foldable Acrylic Intraocular Lenses (IOLs)”
Eugene P. Goldberg, University of Florida
“The Effect of Electropolishing and Magnetoelectropolishing on the Biocompatibility of Porous Nitinol Implant”
Chandan Pulletikurthi, Florida International University |
11:30-11:50 a.m.
11:50-12:10 p.m.
|
“Comparing the Biocompatibility of Electropolished and Magnetoelectropolished Nitinol”
Waseem Haider, Florida International University
“Analytical Comparison of CoCrMo Implant
Passivation using Nitric Acid or Citric Acid”
Stephanie Vass, DePuy Orthopaedics |
12:15-1:30 p.m. |
Attendee Luncheon and Awards Sessions
(Chair: Marc Hendriks, DSM Biomedical; Student Award Chair: Carl Turnquist, Genzyme)
Excellence in Surface Science Award Winner: Gabor Somorjai
"BioInterfaces. The Grand Challenge of Molecular Surface Chemistry" |
Coming Innovations in Medical Devices:
(Chair: Zhengrong Zhou, St. Jude Medical) |
1:30-2:00 p.m.
2:00-2:20 p.m.
|
“Nitric Oxide Materials—A Natural Approach to Creating More Biocompatible Medical Devices”
Melissa M. Reynolds, Colorado State University
“Novel Highly Robust Non-Fouling Surfaces by UV Curing Technology: A Powerful Tool in Device Design”
Jens Thies, DSM Biomedical
|
2:20-2:40 p.m.
2:40-3:00 p.m. |
“Evolution of Prosthetic Heart Valves—Novel Materials and Revolutionary Technologies”
Aditee Kurane, St. Jude Medical
“Evolution of Intravascular Technology”
Yunbing Wang, Abbott Vascular |
| 3:00-3:30 p.m. |
Break |
Academic/Industrial Partnerships Roundtable
(Chair: Steven Goodman, 10H Technology Inc.) |
| 3:30-4:00 p.m. |
Keynote: Colin Fairman, JD, PhD
Turning Ideas into Reality: Creating, Protecting and Managing Patent Portfolios
Senior Associate, Fulbright & Jaworski L.L.P.
|
| 4:00 p.m. |
Jeanine Burmania, MS Biomedical Engineering & Pharmaceutical Science
The Role of the Technology Transfer Office in the Pathway from Collaboration to Commercialization
Licensing Manager, Wisconsin Alumni Research Foundation (WARF), Madison, WI
|
| 4:20 p.m. |
Steven Goodman – Session Chair Introduction to:
Will you be my Partner? Brief “seeking partners” Presentations by any registered attendee (see Submission Instructions).
|
4:25 p.m.
4:30 p.m. |
Jeanine Burmania of the Wisconsin Alumni Research Foundation, is seeking industrial partners interesting in Licensing Medical Device Technologies.
Speaker to be determined
|
| 4:35 p.m. |
Steven Goodman, of 10H Technology and UW-Madison, seeks to assist industrial partners with analytical and microscopic characterization for R&D, QA/QC, and for Regulatory purposes. Also seeks partners in evaluating and developing new technology and business opportunities.
|
4:40 p.m.
4:55 p.m. |
More Speakers to be determined
Steven Goodman, Session Chair.
Closing remarks and “Free” Money to Fund Partnerships – Governmental and other funding sources for Academic and Industrial Partnerships. |
| 5:00 p.m. |
Session ends |
| |
| Keynote Speaker |
 James J. Barry, PhD
Senior Vice President, Corporate Technology Development
Boston Scientific Corp.
James J. Barry, Ph.D., is Sr. Vice President, Corporate Technology Development at Boston Scientific. He oversees the Corporate Research and Development efforts, the Pre-clinical Sciences Department, is responsible for maintaining the company’s product development systems and heads the Technical Executive Committee that is composed of the company’s Vice Presidents of R&D. He leads the company’s efforts in the identification and early development of drug, device and biological systems for potential application in implantable and catheter-based delivery systems. This Corporate Group is the company’s center of excellence in biological approaches to the understanding and treatment of relevant target diseases. These have ranged from traditional therapeutic strategy’s to stem cell/biological matrices and other novel cutting edge approaches.
Dr. Barry joined Boston Scientific in 1992 and was the initiator and champion of the company’s drug eluting stent program. This effort resulted in the TAXUS™ coronary stent which was developed under Dr Barry’s leadership; a paclitaxel-eluting polymeric stent that became the most successful medical device launched with annual sales exceeding $3 billion.
Prior to joining Boston Scientific, Dr. Barry held positions at the Howmedica Division of Pfizer where he initiated their bio-resorbable fracture fixation program and at Kontron Instruments, Inc. where he played a pivotal part in resolving the FDA consent decree (a role for which he had been hired).
Dr. Barry is the author of multiple articles in peer reviewed publications, including the journals of Controlled Release, Biomaterials and several clinical journals in the cardiovascular field. He holds in excess of 35 national and international patents. Dr Barry also represents Boston Scientific’s interests on the Boards of a number of emerging technology companies. Dr. Barry holds a Ph.D. in Biochemistry from the University of Massachusetts-Lowell and a B.A. degree in chemistry from Saint Anselm College. |
